No competing interests declared. The multicentre service evaluation by Ramasamy et al. [1] identified substantial variation in induction drug selection, dosing and pre-emptive vasopressor use during emergency tracheal intubation. The authors advocated standardisation, but their data leave an earlier issue unresolved: whether management was aligned with the haemodynamic risk anticipated before induction. The sub-group distributions are consistent with some risk-adapted prescribing.
